<DOC>
	<DOC>NCT02240654</DOC>
	<brief_summary>This is a descriptive, observational, multi-country European cross-sectional study of new users of dabigatran etexilate that aims to characterise on- and off-label status and other medical characteristics at the time of the first captured prescription of dabigatran etexilate in each database. The study will be conducted using Cegedim Strategic Database (CSD, France), Danish National Databases (Denmark) and Clinical Practice Research Datalink (CPRD, UK).</brief_summary>
	<brief_title>Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe</brief_title>
	<detailed_description>Study Design:</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Inclusion criteria: 1. Have at least 1 year of enrolment in the electronic database. 2. Have not been prescribed dabigatran etexilate during the 1year period prior to the index date.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>